
Ablay Pharma Private Limited
Pharmaceutical company that manufactures, sells, and distributes medical preparations and compounds for various institutions and authorities.
Pharmaceutical company that manufactures, sells, and distributes medical preparations and compounds for various institutions and authorities.
Jammu, Jammu & Kashmir, India
+91-XXXXXXXXXX
-
U24239JK2009PTC002967
002967
Private Limited Indian Non-Government Company
12 Jan 2009
-
-
Unlisted
Roc Jammu
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yash Pal ![]() | Director | 12-Jan-2009 | Current |
Vikas Beniwal ![]() | Director | 12-Jan-2009 | Current |
Harender Singh ![]() | Director | 12-Jan-2009 | Current |
Enhance accessibility to Ablay Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Ablay Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Yash Pal and Vikas Beniwal are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ablay Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ablay Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ablay Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Yash Pal was appointed as a Director was appointed as a Director on 12 Jan 2009 & has been associated with this company since 16 years 1 month .
Vikas Beniwal was appointed as a Director was appointed as a Director on 12 Jan 2009 & has been associated with this company since 16 years 1 month .
Harender Singh was appointed as a Director was appointed as a Director on 12 Jan 2009 & has been associated with this company since 16 years 1 month .
Ablay Pharma Private Limited was registered on 12 Jan 2009 with Roc Jammu & aged 16 years 1 month as per MCA records.
Ablay Pharma Private Limited was incorporated on 12 Jan 2009.
The authorized share capital of Ablay Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.00.
Currently 3 directors are associated with Ablay Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ablay Pharma Private Limited is A-36 Bharat Nagar Talab Tillo, J K - Kashmir India, Jammu, Jammu & Kashmir, 180002.
The corporate identification number (CIN) of Ablay Pharma Private Limited is U24239JK2009PTC002967 and the company number is 002967 as per Ministry of Corporate Affairs (MCA).